Desloratadine

This page contains recent news articles, when available, and an overview of Desloratadine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Desloratadine
(when available)

Pharmacology and use:
Desloratadine is a long-lasting antihistamine. Desloratadine is a second-generation H1-receptor antagonist which has a selective and peripheral H1-antagonist action. Histamine is a chemical that causes many of the signs that are part of allergic reactions, for example, swelling of tissues. Histamine is released from histamine-storing cells (mast cells) and attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be "activated," releasing other chemicals which produce the effects that we associate with allergy. Desloratadine blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation of cells by histamine. Unlike most other antihistamines, Desloratadine does not enter the brain from the blood and, therefore, does not cause drowsiness. For the relief of symptoms of seasonal allergic rhinitis, pruritus, reduction in the number of hives in patients with chronic idiopathic urticaria.

Mechanism Of Action:
Like other H1-blockers, Desloratadine competes with free histamine for binding at H1-receptors in the GI tract, uterus, large blood vessels, and bronchial smooth muscle. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

News Articles on Desloratadine

Allergy Drug Tackles Nasal Congestion: Study  -  ‎Nov 12, 2009‎
In the current study, French and Swedish researchers randomly assigned 584 people with allergic rhinitis to desloratadine (5 milligrams daily) or inactive ... ABC News

Allergy Drug Desloratadine Reduces Nasal Congestion  -  ‎Nov 13, 2009‎
A study has revealed that the allergy drug desloratadine considerably reduces nasal congestion and allergic rhinitis. Allergic rhinitis, more commonly known ... india-server.com

Generic Name: Desloratadine, NeoClarityn, Claramax, Aerius  -  ‎Nov 11, 2009‎
Clarinex (generic name: Desloratadine; brand names include: NeoClarityn / Claramax / Aerius) is an antihistamine used to help relieve the symptoms of ... Pattaya Daily News

AstraZeneca takes Lupin to NJ court over Nexium  -  ‎Nov 9, 2009‎
First go ahead, challenge and then enter into a settlement, Effexor XR, Desloratadine, Ramipril and bunch of other filings. All of these have probably been ... Moneycontrol.com

Schering-Plough Reports Financial Results for 2009 Third Quarter  -  ‎Oct 22, 2009‎
Court for the District of New Jersey against several generic drug manufacturing companies involving generic solid oral dosage forms of desloratadine. ... Reuters

AstraZeneca sues Lupin for 'infringing on' drug patent  -  ‎Nov 10, 2009‎
These include patent settlements with Wyeth for antidepressant Effexor XR and Hatch-Waxman litigation relating to Desloratadine, a generic version of ... Financial Express

Merck & Co earnings climb as Januvia and Isentress impress  -  ‎Oct 23, 2009‎
Revenues from the antihistamine Clarinex (desloratadine) fell 7% to $164 million, due mainly to the effects of currency. As for products SP got hold of ... Pharma Times

Lupin settles patent suit with Schering-Plough  -  Dec 17, 2008
N) relating to desloratadine tablets. The drug is the generic version of Schering-Plough's Clarinex tablets, used to treat allergies. ... Reuters

Desloratadine and Pseudoephedrine ( Systemic).  -  Feb 1, 2006
Desloratadine and Pseudoephedrine ( des-LOR-at-a-deen and soo-doe-e-FED-rin) is a combination of two medicines used to treat nasal congestion (stuffy nose), ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

FDA Approves Clarinex-D 12 Hour  -  Feb 3, 2006
Clarinex (desloratadine) is a nonsedating antihistamine available by prescription for ... Clarinex-D 24 Hour (containing 5 milligrams desloratadine and 240 ... WebMD

Desloratadine Oral : User Ratings covering uses, effectiveness, …  -  Apr 8, 2008
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. ... WebMD

Desloratadine and Fexofenadine Similar for Allergic Rhinitis:...  -  Nov 7, 2005
By Crystal Phend. ANAHEIM, CA -- November 7, 2005 -- Desloratadine (Clarinex) is as effective as fexofenadine (Allegra) for the treatment of allergic ... DG News

… Re-Formulated CLARINEX(R) (Desloratadine) REDITABS(R) Tablets - …  -  Jul 15, 2005
KENILWORTH, NJ, July 15 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that the US Food and Drug Administration (FDA) has approved ... RedOrbit

Desloratadine Proves Safe and Effective for Seasonal Allergic...  -  Mar 18, 2008
By Em Brown, BSN. PHILADELPHIA -- March 18, 2008 -- Positive results of clinical trials with desloratadine have translated into good outcomes in everyday ... DG News

Desloratadine (Systemic).(Drug overview)  -  May 1, 2006
Desloratadine(des-LOR-at-a-deen)is an antihistamine. It is used to relieve the symptoms of hay fever and hives of the skin. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Safety of Desloratadine Syrup in Children*  -  Feb 25, 2005
Background: Allergic rhinitis (AR) and acute urticaria are common childhood maladies. Typically, the first-line treatment options for both include ... RedOrbit

… Court Opinions - IN RE DESLORATADINE PATENT LITIGATION (JPML …  -  Aug 16, 2007
IN RE DESLORATADINE PATENT LITIGATION (JPML 2007) 502 F. Supp.2d 1354 IN RE: ... [fn2] Schering sells desloratadine products covered by the `274 patent for ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

European Commission Approves Aerinaze (Desloratadine 2.5 Mg/ …  -  Aug 4, 2007
Schering-Plough Corporation announced the European Commission (EC) has approved AERINAZE (desloratadine 2.5 mg/pseudoephedrine 120 mg) Modified-Release ... Medical News Today - Medical News Today (press release)

Desloratadine/Pseudoephedrine Combination More Effective Than …  -  Jun 8, 2008
By Chris Berrie. BARCELONA, SPAIN -- June 8, 2008 -- The combination of desloratadine and pseudoephedrine is well tolerated and significantly more effective ... DG News

… CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/pseudoephedrine …  -  Feb 6, 2006
Schering-Plough Corporation (NYSE: SGP) today announced that the US Food and Drug Administration (FDA) has approved CLARINEX-D® 12 HOUR (desloratadine 2.5 ... Medical News Today - Medical News Today (press release)

CHINA BIOPHARMACEUTICALS COMPLETES DESLORATADINE …  -  Jan 1, 2007
China Biopharmaceuticals Holdings, Inc. (BULLETIN BOARD: CHBP), Beijing, a leading Chinese pharmaceutical company focused on the development, ... Free with registration - Worldwide Biotech - AccessMyLibrary.com

Schering Plough Research Institute; Desloratadine plus fluoxetine...  -  Jan 5, 2005
2005 JAN 5 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the pharacokinetics/pharmacodynamics of desloratadine and fluoxetine in health ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Desloratadine May Have Early Effect on Nasal Congestion, Other …  -  Nov 13, 2008
By Sandra Ripley Distelhorst. SEATTLE, Wash -- November 13, 2008 -- Desloratadine is an effective treatment for nasal congestion and other symptoms of ... DG News

China BioPharma completes desloratadine studies in hay fever.  -  Nov 27, 2006
China BioPharma completes desloratadine studies in hay fever. China Biopharmaceuticals Holdings has announced the completion of all required clinical trials ... $9.94 - Pharma Marketletter - Alacra Store

Pharmacology; Desloratadine plus fluoxetine caused no significant …  -  Jan 3, 2005
2005 JAN 3 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the pharacokinetics/pharmacodynamics of desloratadine and fluoxetine in health ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

… European approval of new formulations of AERIUS (Desloratadine)  -  Apr 30, 2007
Schering-Plough markets desloratadine under the brand names AERIUS, AZOMYR and NEOCLARITYN in Europe and as CLARINEX in the United States. ... News-Medical.net

… Holdings Completes All Clinical Trials of Desloratadine for Hay...  -  Nov 21, 2006
Desloratadine is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis. It is also indicated for the symptomatic relief ... $4.95 - PR Newswire - ECNext

… Approves Label Change For Aerius(R) (Desloratadine) For Urticaria...  -  Apr 10, 2008
AERIUS (desloratadine) is a nonsedating antihistamine and is indicated in the ... Schering-Plough markets desloratadine as prescription medicines under the ... Medical News Today - Medical News Today (press release)

Pharmacology; Desloratadine plus fluoxetine caused no significant …  -  Jan 7, 2005
2005 JAN 7 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the pharacokinetics/pharmacodynamics of desloratadine and fluoxetine in health ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

… Clarinex-D 12 Hour (Desloratadine/Pseudoephedrine) Tablet Prescripti...  -  Feb 2, 2006
KENILWORTH, NJ -- February 2, 2006 -- Schering-Plough Corporation today announced that the US Food and Drug Administration (FDA) has approved Clarinex-D® 12 ... DG News

… Prescription Antihistamine, Re-Formulated CLARINEX(R) (desloratadin...  -  Jul 20, 2005
Schering-Plough Corporation (NYSE: SGP) today announced that the US Food and Drug Administration (FDA) has approved re-formulated CLARINEX(R) (desloratadine ... Medical News Today - Medical News Today (press release)

… Laboratories settles Clarinex® (Desloratadine) ANDA patent...  -  Dec 23, 2008
Hyderabad, India, December 23, 2008: Dr. Reddy's Laboratories today announced that it has entered into agreements with Schering and Sepracor which will ... Equity Bulls

… Re-Formulated CLARINEX(R) (desloratadine) REDITABS(R) Tablets - …  -  Jul 15, 2005
FDA Approves Re-Formulated CLARINEX(R) (desloratadine) REDITABS(R) Tablets - Orally Disintegrating Prescription Antihistamine. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… Litigation Settlement with Schering-Plough Corporation for Deslorat...  -  Dec 17, 2008
Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

… CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/pseudoephedrine …  -  Feb 1, 2006
FDA Approves CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/pseudoephedrine 120mg) Tablet Prescription Antihistamine with Decongestant for Seasonal Allergy ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Desloratadine effective for chronic urticaria.(Dermatology)(B...  -  Mar 1, 2005
Desloratadine effective for chronic urticaria.(Dermatology)(Brief Article) ... find Internal Medicine News articles. VICTORIA, BC -- An open-label trial of ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: Perrigo Settles Desloratadine Patent Litigation. - PR ...  -  Dec 4, 2008
Perrigo Settles Desloratadine Patent Litigation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

… Holdings Completes All Clinical Trials of Desloratadine for Hay...  -  Nov 21, 2006
China Biopharmaceuticals Holdings Completes All Clinical Trials of Desloratadine for Hay Fever. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Desloratadine effective for chronic urticaria.(Dermatology)(Brief...  -  Mar 1, 2005
VICTORIA, BC -- An open-label trial of Canadian patients seen in regular clinics and offices has confirmed that treatment with desloratadine for chronic ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones

FDA approved desloratadine 2.5 mg/pseudoephedrine 120 mg (Clarinex- …  -  Mar 1, 2006
FDA approved desloratadine 2.5 mg/pseudoephedrine 120 mg (Clarinex-D 12 Hour, Schering-Plough) extended-release tablets as a treatment for nasal and ... $9.94 - Formulary - Alacra Store

… The FDA has approved re-formulated Clarinex (desloratadine 2.5 mg...  -  Aug 1, 2005
The FDA has approved re-formulated Clarinex (desloratadine 2.5 mg and 5 mg) Reditabs tablets for the treatment of allergy symptoms caused by both perennial ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

… (R) Technology Used in CLARINEX(R) (desloratadine) Reditabs(R) Re- …  -  Aug 25, 2005
CIMA LABS' OraSolv(R) Technology Used in CLARINEX(R) (desloratadine) Reditabs(R) Re-formulation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Drug Delivery; OraSolv technology used in Clarinex (desloratadine)  -  Sep 20, 2005
2005 SEP 20 - (NewsRx.com) -- Cima Labs, Inc., a Cephalon company (CEPH), announced that Schering-Plough Corporation plans to market an orally ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Cerep SA seeking buyer for Cerep SA-Chemistry Research - Deal …  -  Dec 18, 2006
The first NDA seeks clearance to market desloratadine syrup…of age. The second NDA seeks approval to market desloratadine in… ... Pay-Per-View - deals - Alacra Store

… (R) Technology Used in CLARINEX(R) (desloratadine) Reditabs(R) Re- …  -  Aug 25, 2005
...a Cephalon company , announced today that Schering-Plough Corporation plans to market an orally disintegrating version of CLARINEX(R) (desloratadine), ... $4.95 - PR Newswire - ECNext

Allergic Rhinitis; Data show morning is the most difficult time for...  -  Dec 6, 2005
...s Clarinex (desloratadine) significantly reduces morning symptoms of seasonal ... "In the study, patients taking once-daily desloratadine experienced relief ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Diphenhydramine Has Decongestant Effect for Seasonal Allergies: …  -  Nov 23, 2005
Dr. Raphael and colleagues found significant improvements in nasal symptoms from high dose diphenhydramine compared to a standard dose of desloratadine. ... DG News

Competitors by Product Report  -  Dec 20, 2008
Children's Claritin (Loratidine); Clarinex (Desloratadine); Clarinex Reditabs/Clarinex ... Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine) ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 11, 2006
Buyer (Total: 75). Clarinex Syrup (Desloratadine); Claritin (Loratadine); Clarinex (Desloratadine); Clarinex Reditabs (Desloratadine) ... $250.00 - Revere Reports - Revere

Company Update: Lupin  -  Dec 22, 2008
Lupin has settled with Schering-Plough all ongoing litigations relating to Desloratadine tablets, the generic version of Schering-Plough's allergy drug ... Livemint

… EU Approval of Two New Formulations of AERIUS(R) (Desloratadine). ...  -  Apr 27, 2007
Schering-Plough markets desloratadine under the brand names AERIUS, AZOMYR and NEOCLARITYN in Europe and as CLARINEX (R) in the United States. ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Heart Rhythm Disturbances Associated With Rupatadine: A Case Series …  -  Oct 2, 2008
19 For example, desloratadine, the main metabolite of rupatadine, has been shown to release histamine from cardiac mast cells. 20 ... Nature.com

Benadryl edges Clarinex for hay fever  -  May 19, 2006
For the desloratadine group, it was 21 percent. Compared to placebo and desloratadine, diphenhydramine provided significant improvement in scores for all ... RedOrbit

Competitors by Product Report  -  Sep 13, 2008
Children's Claritin (Loratidine); Clarinex (Desloratadine); Clarinex Reditabs/Clarinex ... Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine) ... $75.00 - Revere Reports - Revere

… la evaluación de AERIUS(R) (Desloratadine) según las directrices...  -  Sep 7, 2006
Schering-Plough es una compañía de cuidados médicos basada en la investigación con importantes productos sanitarios de prescripción, consumo y aplicación ... elEconomista.es

International Approvals: Aerius, Sebivo, Rapydan  -  May 7, 2007
May 7, 2007 — The European Commission (EC) has approved desloratadine 2.5- and ... Desloratadine orally disintegrating tablets (Clarinex RediTabs) and syrup ... Medscape

Press Release: Data Show Morning Is the Most Difficult Time for...  -  Nov 8, 2005
CLARINEX(R) (desloratadine) 5 mg Tablets significantly reduce morning ... "In the study, patients taking once-daily desloratadine experienced relief of ... Pay-Per-View - PR Newswire - HighBeam Research

… la evaluación de AERIUS(R) (Desloratadine) según las directrices...  -  Sep 7, 2006
Schering-Plough Corporation ha anunciado hoy el lanzamiento de dos ensayos clínicos multinacionales y un cambio importante en el etiquetado de AERIUS ... elEconomista.es

Efficacy and central nervous system impairment of newer-generation …  -  Jun 1, 2006
The clinical evidence confirms that desloratadine, cetirizine and ... Cetirizine 10 mg, desloratadine 5 mg and fexofenadine HCl 180 mg once daily are three ... Free with registration - Southern Medical Journal - AccessMyLibrary.com

Competitors by Product Report  -  Sep 30, 2006
Children's Claritin (Loratidine); Clarinex (Desloratadine); Clarinex Reditabs (Desloratadine); Clarinex Syrup (Desloratadine); Claritin (Loratadine) ... $75.00 - Revere Reports - Revere

ANTIHISTAMINE (Oral route, Parenteral route, Rectal route).(Drug …  -  May 1, 2007
Desloratadine and fexofenadine have not been studied in pregnant women. ... It is not known yet whether cetirizine, desloratadine, or loratadine cause these ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Levocetirizine in the Treatment of Chronic Idiopathic Urticaria: A …  -  May 1, 2006
Comparison of levocetirizine and desloratadine in the inhibition of wheals and flares by histamine prick tests has been performed. ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

Leukotriene inhibitors in the treatment of allergy and asthma.  -  Jan 1, 2007
...(34) Another randomized study comparing the antihistamine desloratadine (Clarinex) ... (35) There was no benefit to adding montelukast to desloratadine. ... Free with registration - American Family Physician - AccessMyLibrary.com

Competitors by Product Report  -  Sep 30, 2006
Chlor-Trimeton Allergy/Decongestant (Chlorpheniramine Maleate/Pseudoephedrine); Clarinex D-12 Hour (Desloratadine/Pseudoephedrine); Clarinex D-24 Hour ... $75.00 - Revere Reports - Revere

Market Live from BSE - NSE, Latest Market Commentary | Economic …  -  Dec 18, 2008
10:40 am: Lupin Ltd has settled all ongoing Hatch-Waxman litigation relating to desloratadine tablets, the generic version of Schering-Plough's Clarinex ... Economic Times

Merger and Acquisition Scenario  -  Apr 7, 2007
Clarinex (Desloratadine); Allegra (Fexofenadine Hydrochloride); Xyzal (Levocetirizine Dihydrochloride); Xopenex (Levalbuterol Hydrochloride) ... $250.00 - Revere Reports - Revere

FDA Approves CLARINEX-D(R) 24 HOUR Prescription-Strength Once- …  -  Mar 4, 2005
And the decongestant efficacy of CLARINEX-D 24 HOUR, when measured by nasal congestion, was significantly greater than desloratadine during the treatment ... RedOrbit

Seasonal Allergic Rhinitis - FDA Approves CLARINEX-D Gel 24 HOUR …  -  Mar 5, 2005
And the decongestant efficacy of CLARINEX-D 24 HOUR, when measured by nasal congestion, was significantly greater than desloratadine during the treatment ... Medical News Today - Medical News Today (press release)

FDA Approvals: Clarinex, Abilify, Isovorin  -  Mar 10, 2005
On March 3, the FDA approved desloratadine 5 mg plus pseudoephedrine sulfate 240 mg ... Desloratadine (Clarinex, made by Schering-Plough Corp. ... Medscape

Merger and Acquisition Scenario  -  May 5, 2007
Clarinex (Desloratadine); Allegra (Fexofenadine Hydrochloride); Xyzal (Levocetirizine Dihydrochloride); SEP-227162 (Serotonin/Norepinephrine Reuptake ... $250.00 - Revere Reports - Revere

Press Release: FDA Approves XYZAL(R) (levocetirizine dihydrochloride)...  -  Feb 19, 2008
Article: Schering-Plough Announces CLARINEX(R) (desloratadine) Tablets ... ... Article: Schering-Plough Submits U.S. Application for Desloratadine for ... ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Jun 16, 2007
Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere

Otite moyenne allergique du lapin, place des anti-H1 ?  -  Jul 2, 2008
La desloratadine est un des métabolites actifs de la loratadine. Les résultats sont clairs l'hydroxyzine fait mieux sur l'ensemble des paramètres que la ... Allergique - Allergique (Abonnement)

Merger and Acquisition Scenario  -  Jan 27, 2007
Clarinex (Desloratadine); Allegra (Fexofenadine Hydrochloride); (S)-Amlodipine (Calcium Channel Blocking Agent); SEP-226330 (Norepinephrine/Dopamine ... $250.00 - Revere Reports - Revere

Press Release: Takeda and TAP to Promote Sucampo's AMITIZA(R) in …  -  Feb 26, 2007
Article: Schering-Plough Submits U.S. Application for Desloratadine for ... PR Newswire; September 5, 2000 ; 605 words ... ... desloratadine for the ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Benadryl found ineffective as infant sleep aid.(Clinical...  -  Aug 1, 2006
Article: Diphenhydramine more effective than desloratadine or ... Clinical Advisor; January 1, 2007 ; 700+ words ...DIPHENHYDRAMINE MORE EFFECTIVE THAN ... Pay-Per-View - Pediatric News - HighBeam Research

Sepracor Announces Second Quarter 2005 Operating Results  -  Jul 19, 2005
CLARINEX(R) brand desloratadine - Sepracor earns royalties from Schering-Plough Corporation on sales of all formulations of CLARINEX brand desloratadine in ... RedOrbit

SEPRACOR REPORTS 2ND QTR 2005 NET LOSS OF $7.4 MILLION.  -  Sep 1, 2005
CLARINEX(R) brand desloratadine - Sepracor earns royalties from Schering-Plough Corporation on sales of all formulations of CLARINEX brand desloratadine in ... Entrepreneur

Antihistamines (Systemic).(Drug overview)  -  May 1, 2006
Desloratadine and fexofenadine have not been studied in pregnant women. ... It is not known yet whether cetirizine, desloratadine, or loratadine cause these ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

AERIUS Now Approved For Use In Intermittent And Persistent Allergic …  -  Sep 8, 2006
AERIUS (desloratadine) is a nonsedating prescription antihistamine for the treatment of symptoms associated with allergic rhinitis (including intermittent ... Medical News Today - Medical News Today (press release)

(s.)Generic name product may be available in Canada  -  Oct 27, 2005
Desloratadine and fexofenadine have not been studied in pregnant women. ... It is not known yet whether cetirizine, desloratadine, or loratadine cause these ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Jun 23, 2007
Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride). Digestive System. Phase I/Phase II Clinical Stage ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 1, 2007
Clarinex (Desloratadine); Allegra (Fexofenadine Hydrochloride); Xyzal (Levocetirizine Dihydrochloride); SEP-227162 (Serotonin/Norepinephrine Reuptake ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 2, 2006
Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine); (S)-Amlodipine (Calcium Channel Blocking Agent); SEP-226330 (Norepinephrine/Dopamine ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Target (Total: 75). Clarinex Syrup (Desloratadine); Clarinex (Desloratadine); Clarinex Reditabs (Desloratadine); Claritin (Loratadine) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 14, 2008
Buyer (Total: 20). Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 27, 2008
Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 29, 2008
Xyzal (Levocetirizine Dihydrochloride); Clarinex (Desloratadine); Allegra (Fexofenadine Hydrochloride). Digestive System. Phase I/Phase II Clinical Stage ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 2, 2008
Buyer (Total: 20). Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Buyer (Total: 75). Clarinex Syrup (Desloratadine); Clarinex (Desloratadine); Clarinex Reditabs (Desloratadine); Claritin (Loratadine) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 2, 2008
Buyer (Total: 107). Clarinex Syrup (Desloratadine); Clarinex Reditabs/Clarinex Syrup (Desloratadine); Claritin (Loratadine); Clarinex (Desloratadine) ... $250.00 - Revere Reports - Revere

Press Release: Video: For Fall Allergy Season LPGA Player Jill McGill...  -  Sep 15, 2008
Article: FDA Approves CLARINEX(R) (Desloratadine) Syrup for Relief of . ... Desloratadine Marketed in U.S. Under Brand Name CLARINEX(R), In EU as AERIUS(TM) ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Jan 19, 2008
Clarinex (Desloratadine); Allegra (Fexofenadine Hydrochloride); Xyzal (Levocetirizine Dihydrochloride); BIA 2-093 (Eslicarbazepine Acetate) ... $250.00 - Revere Reports - Revere

Efficacy and central nervous system impairment of newer-generation …  -  Jun 1, 2006
Newer-generation antihistamines, such as desloratadine, cetirizine and fexofenadine, ... The clinical evidence confirms that desloratadine, cetirizine and ... Pay-Per-View - Southern Medical Journal - HighBeam Research

Merger and Acquisition Scenario  -  Nov 22, 2008
Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine); (S)-Amlodipine (Calcium Channel Blocking Agent); SEP-226330 (Norepinephrine/Dopamine ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 30, 2008
Buyer (Total: 20). Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 1, 2008
Allegra (Fexofenadine Hydrochloride); Xyzal (Levocetirizine Dihydrochloride); Clarinex (Desloratadine); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 15, 2008
Target (Total: 107). Clarinex Syrup (Desloratadine); Clarinex Reditabs/Clarinex Syrup (Desloratadine); Clarinex (Desloratadine); Claritin (Loratadine) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jul 12, 2008
Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 13, 2008
Buyer (Total: 107). Clarinex Syrup (Desloratadine); Clarinex Reditabs/Clarinex Syrup (Desloratadine); Claritin (Loratadine); Clarinex (Desloratadine) ... $250.00 - Revere Reports - Revere

Efficacy and central nervous system impairment of newer-generation …  -  Jun 1, 2006
Newer-generation antihistamines, such as desloratadine, cetirizine and fexofenadine, ... The clinical evidence confirms that desloratadine, cetirizine and ... $4.95 - Southern Medical Journal - ECNext

Merger and Acquisition Scenario  -  Apr 15, 2006
Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine); (S)-Amlodipine (Calcium Channel Blocking Agent) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Feb 16, 2008
Buyer (Total: 20). Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 22, 2008
Buyer (Total: 20). Clarinex (Desloratadine); Xyzal (Levocetirizine Dihydrochloride); Allegra (Fexofenadine Hydrochloride); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 11, 2006
Allegra (Fexofenadine Hydrochloride); Clarinex (Desloratadine); (S)-Amlodipine (Calcium Channel Blocking Agent) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 1, 2008
Allegra (Fexofenadine Hydrochloride); Xyzal (Levocetirizine Dihydrochloride); Clarinex (Desloratadine); Omnaris (Nasal Spray Ciclesonide) ... $250.00 - Revere Reports - Revere

Brand Names/Synonyms:
Desloratadine is also known by the following brand names and/or synonymsAerius; Alavert; Clarinex; Clarinex Reditabs; Claritin; Claritin Reditabs; Descarboethoxyloratadine; Descarboethoxyoratidine; Desloratadine; Desloratadine [Usan]; Desloratidine; Loratadine; Sch 34117

Drug Category:
Desloratadine is categorized under the following by the FDA: Antihistamines; Antihistamines; ATC:R06AX27

Dosage Forms:
SYRUP; TABLET

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
Not Available





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy